Shanghai Pharmaceuticals Holding Co., Ltd

Symbol: SHPMF

PNK

1.21

USD

Markedspris i dag

  • 10.5395

    P/E-forhold

  • -0.1533

    PEG Ratio

  • 6.25B

    MRK Cap

  • 0.01%

    DIV Udbytte

Shanghai Pharmaceuticals Holding Co., Ltd (SHPMF) Årsregnskaber

På diagrammet kan du se standardtallene i dynamik for Shanghai Pharmaceuticals Holding Co., Ltd (SHPMF). Virksomhedens omsætning viser gennemsnittet af NaN M, som er NaN % gowth. Den gennemsnitlige bruttofortjeneste for hele perioden er NaN M, som er NaN %. Den gennemsnitlige bruttofortjeneste er NaN %. Væksten i nettoindkomst for virksomheden sidste år er NaN %, hvilket svarer til NaN % % i gennemsnit for hele virksomhedens historie.,

Balance

Når vi dykker ned i den skattemæssige udvikling for Shanghai Pharmaceuticals Holding Co., Ltd, ser vi en gennemsnitlig aktivvækst. Det er interessant, at denne rate ligger på , hvilket afspejler både virksomhedens op- og nedture. Når man sammenligner kvartal for kvartal, justeres dette tal til . Et kig tilbage på det seneste år afslører en samlet aktivændring på NaN. Aktionærværdi, som vist ved den samlede egenkapital, er vurderet til NaN i rapporteringsvalutaen. Ændringen fra år til år i dette aspekt er NaN%.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994

balance-sheet.row.cash-and-short-term-investments

040669.93701522390.4
22296.2
18152.8
18694.7
14842.7
11970.9
12039.8
11608.6
12978.8
13528.3
14852.7
6341.6
1229.2
1046.4
665.2
564
430.1
522.7
555.3
675.2
587.3
699.2
435.7
258.9
63.2
36.2
30.6
0

balance-sheet.row.short-term-investments

010152.29613.6-1242.8
-1226.3
-1362.9
-1434.9
0.6
4.1
0.8
0.5
0.3
2.9
2.7
3.2
7.3
9.2
35.8
62.5
115.9
92.3
43.1
3.1
50.6
100
0.7
0
0
0
0
0

balance-sheet.row.net-receivables

083736.47663465885.8
59921.7
53944.4
48324.7
35415.5
30982.1
27895.5
23605.7
18170.1
15008.5
12701.1
9322.2
3419.6
2853.3
2751.2
2582.3
2539.6
3002.4
2474.6
1923.1
1615.8
53.1
98.9
92.1
30.2
13.7
19.7
0

balance-sheet.row.inventory

036623.434460.227104
24088.3
24877.4
25024
17270
16415.8
15090.6
13088.2
10996.5
9809.7
8297.5
5040.7
1974.5
1622.8
1364.2
1191.4
1351.1
1223
1370.2
1170
824
610.9
571.3
608.5
125.3
99
73
0

balance-sheet.row.other-current-assets

01404.21403.71114.2
1256.7
1117
1234.5
1114.1
898.2
559.3
355.9
369.6
455.4
144.5
2.7
-121.4
0.1
0.1
15.3
21.5
2.5
0
0
0.3
1329.2
1201.6
1068.6
120.2
95.5
86.4
189.1

balance-sheet.row.total-current-assets

0162433.9149512.9116494.4
107562.9
98091.6
93277.9
68642.3
60266.9
55585.2
48658.3
42515
38801.9
35995.8
20707.2
6502
5522.6
4780.7
4353
4342.2
4750.5
4400.2
3768.3
3027.5
2692.4
2307.5
2028
339
244.4
209.7
189.1

balance-sheet.row.property-plant-equipment-net

01787316185.315390.7
14220.6
12717.7
10194.6
8691.6
6561.1
5693.4
4993.7
4808.9
4259.4
4039.6
3978.5
892.4
913.5
1129.5
1184.6
979.6
1033.1
1077.1
1058.1
698.4
577.2
511.2
420
217.7
223.6
203
222.3

balance-sheet.row.goodwill

011393.311335.911239
11342.3
10789.9
11345.3
6606.7
5848
4815.6
4473.4
3643.3
3172.8
2988.9
422.8
0
0
0
0
0
3
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

06361.36586.76308.7
5419.1
4142
4283.2
2702.4
2767.1
1984.2
1861.6
1540.3
1406.7
1276.2
875.9
432.5
446.6
526.2
366.1
73.7
143.9
186.1
195.5
183.7
84.7
91.1
96.7
0.3
0.3
0.3
0

balance-sheet.row.goodwill-and-intangible-assets

017754.717922.717547.6
16761.3
14931.9
15628.5
9309.1
8615.1
6799.8
6335
5183.6
4579.5
4265.1
1298.7
432.5
446.6
526.2
366.1
73.7
146.9
186.1
195.5
183.7
84.7
91.1
96.7
0.3
0.3
0.3
0

balance-sheet.row.long-term-investments

0450.51863.611778.3
8888.9
6795.3
6083.4
4802.6
4492.5
3914.6
2932.5
2845.9
2691.4
2634.7
1597.4
277.7
330.2
299.6
701.1
846.5
393.5
404.8
330.4
295.6
36.6
125.2
0
0
0
0
0

balance-sheet.row.tax-assets

01716.91534.71367.5
1359.4
1222.5
1037.9
566.3
468.3
316.3
264.6
199.8
191.7
178.6
150.2
80.3
47.4
29.1
0
0
0
86.6
50.6
88
3.1
-111.6
0
0
0
0
0

balance-sheet.row.other-non-current-assets

011743.611115.7856.9
392.5
3267.5
657.1
2332.6
2338.8
2035
1156.4
758.3
544.9
554
437
944.1
990.4
720.9
73.7
134.1
140.1
86.6
50.6
88
144.4
20.7
66.5
35.6
33.8
36.8
10.3

balance-sheet.row.total-non-current-assets

049538.74862246941.1
41622.7
38934.8
33601.5
25702.2
22475.8
18759
15682.2
13796.5
12267.1
11672
7461.8
2155
2232.9
2344.9
2325.5
2033.8
1713.6
1754.7
1634.5
1265.7
842.9
748.2
583.2
253.6
257.6
240.2
232.6

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

0211972.5198134.9163435.5
149185.7
137026.4
126879.3
94344.5
82742.7
74344.2
64340.6
56311.5
51069
47667.8
28169
8657
7755.5
7125.6
6678.6
6376.1
6464.2
6154.8
5402.8
4293.1
3535.3
3055.6
2611.2
592.5
502.1
449.8
421.8

balance-sheet.row.account-payables

054632.551565.541995.4
37792.2
36872.5
35148
27295.2
25985.1
24436.9
20435.9
16875.8
14574.9
12659.5
8667.7
3974.2
3096
2689.7
2061.8
1650.6
1823.1
1534.1
1377.1
965.8
687.8
698.9
718.7
62.2
56.8
36.6
0

balance-sheet.row.short-term-debt

0385243100023096.6
29107.2
24327.3
22038.7
13803.5
9646.7
10679.3
7953.1
5924.4
4900.8
5675.5
4818.4
1691.1
1919.5
1999.5
2148.3
2309.9
2057.2
1897.7
1511
1131.2
1578
1308.8
984
195.8
188.3
103.1
0

balance-sheet.row.tax-payables

01217.21440.81692.7
1478.1
1215.4
1042.2
1141.4
642.5
612
546.5
393.6
415.9
393.1
254.3
56.8
29
-0.4
19.3
-49.8
-22.7
-16.1
-14.5
6.2
-4.5
-5.7
-10.8
11.5
3.9
0.4
0

balance-sheet.row.long-term-debt-total

07336.27561.48592
2685.1
10289.9
9620.3
2958.8
2836.3
93.4
105.4
125.2
40.8
52.3
66.1
22.1
25.1
3
1.2
103.2
102.1
89.7
30.8
17.5
2.6
1.6
15.6
21.5
33.7
100.7
0

Deferred Revenue Non Current

0633.5534.62349.1
2224.1
1278.7
503.3
495.8
589.7
367.9
554.3
0.5
0.5
160.4
156.9
28.1
30.4
32.3
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

06291.96384.99232.4
5018.6
1188.6
2698.4
8533.1
5481.5
4310.4
3613.5
2898.7
2622.4
2521
2431.5
592.8
566.1
437.4
377.7
283.1
392.4
463
444.3
316.3
293.5
196.8
172.8
27.4
34.2
26.4
130.9

balance-sheet.row.total-non-current-liabilities

09274.69441.412545
6311.9
13032.8
11736.3
5036.8
4794.9
1109.6
1238.9
1611.6
1270.1
830.4
367.2
76.4
84.1
40.8
23.8
126.6
130.4
132.6
70.8
61.6
-9.3
1.2
22.3
21.5
33.7
100.7
94.3

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

01550.11301.61434.3
1501
1155.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

0131646.4120132.5104369.3
94444.9
87640.5
80446.1
54668.6
45908.3
40536.2
33241.4
27310.5
23368.2
21686.4
16284.8
6334.6
5665.8
5167.3
4611.7
4370.2
4403.1
4027.4
3403.2
2474.9
2550
2205.7
1897.8
306.9
313
266.9
225.2

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

03703.33697.52842.1
2842.1
2842.1
2842.1
2688.9
2688.9
2688.9
2688.9
2688.9
2688.9
2688.9
1992.6
569.2
569.2
569.2
474.3
474.3
474.3
474.3
316.2
316.2
229.6
229.6
153
113
58
58
58

balance-sheet.row.retained-earnings

033822.332479.928598.6
25054.4
21970.9
19330.6
16578.3
14138.4
11961
10009.3
8252.6
6718.3
5196.3
3117
437.3
304.1
263
301.1
279
286.7
282.1
168.9
154.9
123.3
32.5
64.9
17.3
0.1
0
16.5

balance-sheet.row.accumulated-other-comprehensive-income-loss

01532.11553.91565.1
1152.1
531.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

029466.429331.716353.7
16306.2
16315
16840.8
14763.6
14795.2
15280.4
15123.9
15012.3
15232.1
15193.3
4024.9
827.1
815.8
809.2
980
1004.3
1002.2
973.4
1074.5
1034.2
441.2
365.8
380.1
155.2
131
125
122.2

balance-sheet.row.total-stockholders-equity

068524.16706349359.5
45354.7
41659.1
39013.6
34030.8
31622.6
29930.3
27822.1
25953.8
24639.3
23078.5
9134.6
1833.5
1689.1
1641.4
1755.5
1757.6
1763.3
1729.8
1559.6
1505.3
794
627.8
598
285.6
189.1
183
196.6

balance-sheet.row.total-liabilities-and-stockholders-equity

0211972.5198134.9163435.5
149185.7
137026.4
126879.3
94344.5
82742.7
74344.2
64340.6
56311.5
51069
47667.8
28169
8657
7755.5
7125.6
6678.6
6376.1
6464.2
6154.8
5402.8
4293.1
3535.3
3055.6
2611.2
592.5
502.1
449.8
421.8

balance-sheet.row.minority-interest

011801.910939.49706.7
9386.1
7726.9
7419.7
5645
5211.9
3877.7
3277
3047.2
3061.6
2903
2749.7
488.9
400.7
316.9
311.5
248.3
297.8
397.7
440
312.9
191.3
222.1
115.5
0
0
0
0

balance-sheet.row.total-equity

080326.178002.559066.2
54740.7
49385.9
46433.3
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

010602.711477.210535.6
7662.7
5432.4
4648.6
4803.2
4496.6
3915.4
2933
2846.2
2694.4
2637.3
1600.6
285
339.3
335.5
763.6
962.4
485.8
448
333.5
346.2
136.6
125.9
55.6
0.4
0.4
0.9
0

balance-sheet.row.total-debt

045860.238561.431688.6
31792.3
34617.1
31659
16762.3
12483
10772.7
8058.5
6049.6
4941.5
5727.8
4884.5
1713.2
1944.6
2002.4
2149.6
2413.2
2159.3
1987.3
1541.9
1148.6
1580.5
1310.4
999.6
217.3
222
203.8
0

balance-sheet.row.net-debt

015342.5111609298.3
9496.1
16464.3
12964.3
1920.2
516.2
-1266.3
-3549.5
-6928.9
-8583.9
-9122.3
-1453.9
491.3
907.4
1373
1648.1
2099
1728.9
1475.1
869.8
611.9
981.3
875.4
740.7
154.2
185.8
173.2
0

Pengestrømsopgørelse

Det økonomiske landskab for Shanghai Pharmaceuticals Holding Co., Ltd har set en bemærkelsesværdig ændring i det frie cash flow i løbet af den sidste periode, hvilket udviser et skift på NaN. Virksomheden udvidede for nylig sin aktiekapital ved at udstede NaN, hvilket markerer en forskel på NaN i forhold til det foregående år. Virksomhedens investeringsaktiviteter resulterede i et nettokasseforbrug på NaN i rapporteringsvalutaen. Dette er en forskydning på NaN fra året før. I samme periode har virksomheden registreret NaN, NaN og NaN, som er væsentlige for forståelsen af virksomhedens investerings- og afdragsstrategier. Virksomhedens finansieringsaktiviteter førte til et nettokasseforbrug på NaN, med en forskel fra år til år på NaN. Desuden afsatte virksomheden NaN til udbetaling af udbytte til sine aktionærer. Samtidig foretog virksomheden andre finansielle manøvrer, kaldet NaN, som også påvirkede pengestrømmen betydeligt i denne periode. Disse komponenter tegner tilsammen et omfattende billede af virksomhedens økonomiske status og strategiske tilgang til likviditetsstyring.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998

cash-flows.row.net-income

05166.669926274.6
5605.3
4830.7
4456.3
4057.8
3829.7
3364.4
2992
2626.6
2460.6
2446
1779
263.5
129.4
95.5
90.5
71.4
138.5
207.5
163.1
174.8
204.7
110.8
89.8

cash-flows.row.depreciation-and-amortization

02187.12222.42139.8
2137.8
1885
1169.5
840
746.1
672.6
585
549.7
536.6
479.2
382.7
93.2
94.2
96.4
69.1
59.1
74.2
70.3
72.3
50.4
50.1
43.4
21.4

cash-flows.row.deferred-income-tax

0-194.8-131.9165
-233.9
-217.7
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

0194.8131.9-165
233.9
217.7
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

0-4345.5-4680-3398.7
-2013.7
-2571
-3711.7
-2291.7
-2635.8
-2747.8
-2234.2
-2275.2
-2026.7
-942.8
-368.4
62.9
-104
109.2
298.3
-148.2
-242.3
-230.7
-231
-171.1
-101.2
-61.8
-464.7

cash-flows.row.account-receivables

0-6432.4-10081.4-6155.5
-4072.2
-5083.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

0-2303.8-7111.7-3201
932.6
63.1
-2842.9
-423
-942.7
-1943.7
-1587
-1179.7
-1466.4
-1565.9
-859.2
-323.3
-270.1
-12.3
153.4
-158.7
71.3
-300
-209.9
-206.2
-39.7
75.8
-509.9

cash-flows.row.account-payables

04585.5126455792.8
1359.7
2667.2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

0-194.8-131.9165
-233.9
-217.7
-868.8
-1868.8
-1693.1
-804.2
-647.3
-1095.4
-560.3
623.1
490.8
386.2
166.1
121.5
144.9
10.5
-313.6
69.3
-21.1
35.1
-61.5
-137.6
45.1

cash-flows.row.other-non-cash-items

02223.3208.945.6
1115.4
1877.7
1221.1
42.8
6.7
60.1
-7.1
72.3
180.3
-210
-107.2
244.6
166.1
187.8
125.1
90.7
91.2
-46.6
96.5
11.7
-7.4
72.2
70.4

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-2970.6-2684.9-4118.8
-3010
-2753.1
-1943
-2007.3
-2119.3
-1720.5
-1291.5
-905.1
-708.9
-413.5
-550.3
-80
-90.5
-192.3
-151.6
-198.1
-254.4
-169.6
-279.4
-144.7
-141.1
-52.5
-169.9

cash-flows.row.acquisitions-net

0-356.622.5-1039.3
-2045.7
-693.7
-5197.5
-913.6
-1738.7
-602.7
-1083.2
-455.3
-414.2
-4017.5
-2001.5
4
111.2
20.7
218.2
270.2
341.7
176.7
56.5
157.5
142.3
0.2
0

cash-flows.row.purchases-of-investments

0-27376.7-39683.8-3147.8
-4490.9
-1041.4
-1047.6
-4461.3
-2600.6
-1887.9
-707.9
35.8
20.1
41.6
-1325.4
-6.3
-23.2
-13
-22.6
-159.4
-190.1
-344.6
-78.7
-405
-102.3
-175.8
-31.2

cash-flows.row.sales-maturities-of-investments

027861.4302673288.2
4806.1
1271.6
1331.8
5119.4
3099.4
2055.4
976.9
251
179.6
476.3
430.4
36.3
62.1
22.5
108.9
10.3
122.9
102.5
75.4
334.2
122.2
2.1
4.9

cash-flows.row.other-investing-activites

0350.6-394-997.8
3034.8
-1367.7
-836.4
-92.2
469.7
246.6
261.1
216.5
542.3
164.3
703.8
3.9
290.2
9.2
66.6
72.1
87.3
7.1
182.9
12.8
1.2
0.3
-0.1

cash-flows.row.net-cash-used-for-investing-activites

0-2491.9-12473.1-6015.6
-1705.7
-4584.3
-7692.7
-2355
-2889.5
-1908.9
-1844.6
-892.8
-401.3
-3790.4
-2743
-46.1
349.8
-173.6
1.3
-275
-234.2
-404.6
-99.8
-202.7
-120
-225.8
-196.2

cash-flows.row.debt-repayment

0-72338.3-59808.7-52214.6
-47575.5
-38340.3
-53206.6
-22044.2
-18181.3
-18367.5
-13253.9
-10475.4
-8897.8
-12753.3
-5212.4
-3352.6
-3656.8
-3091.2
-4245.5
-3786.5
-3967.5
-204.2
-289.3
-2536.2
-1871.5
-1822.2
-1445.9

cash-flows.row.common-stock-issued

0000
0
0
2624.8
21.8
905.6
301.4
17.2
35.5
55.1
0
2046.4
6.9
24.3
0
0
0
7.2
0.9
4.5
606.4
0
0
263.2

cash-flows.row.common-stock-repurchased

0000
0
0
60659.6
25613.7
18697.4
19978.7
14169.7
11301.7
7764.4
0
4038.1
3061.5
3581.5
0
0
0
4170.7
595
537.4
1427.5
0
0
1703.9

cash-flows.row.dividends-paid

0-3981.2-3093.9-2675.9
-2418.4
-2584.2
-2357.8
-1750.2
-1443.5
-1378.2
-1251.6
-1055.4
-891.2
-775.3
-545.6
-136.7
-196
-141.8
-139.2
-210.2
-128.4
-148.3
-122.9
-49.7
-126.5
-50.4
-73

cash-flows.row.other-financing-activites

076551.475041.256456.1
48732.6
38598.7
-193.7
26087.3
19366.6
20080.6
13539.5
10773.8
7707.9
24171.7
6037.1
3092.2
3556.4
2897.7
3985.6
4084.9
4177.8
595.9
541.9
2053.9
2135.9
2110.2
1935.8

cash-flows.row.net-cash-used-provided-by-financing-activities

0231.912138.61565.6
-1261.2
-2325.8
7526.3
2314.7
647.4
636.4
-948.8
-721.6
-2026
10643.1
2325.4
-390.3
-272.1
-335.3
-399.1
88.3
89.1
244.3
134.2
74.5
137.9
237.5
680

cash-flows.row.effect-of-forex-changes-on-cash

0-5.6-12.4-50.3
-17.6
-1.6
67.4
-18.8
-2.6
10.7
2.8
-14.6
22.7
-280.8
-5.5
0.5
1.4
-1.5
2
-2.5
1.7
0
0
0
0
-0.2
0

cash-flows.row.net-change-in-cash

02965.94396.4561.1
3860.2
-889.3
3036.1
2589.7
-298.1
87.4
-1454.9
-655.5
-1253.8
8344.3
1263.1
228.2
364.9
-21.5
187.3
-116.2
-81.7
-159.9
135.3
-62.5
164.2
176.1
200.6

cash-flows.row.cash-at-end-of-period

027499.824533.920137.5
19576.4
15716.3
16605.6
13569.4
10979.7
11277.9
11190.4
12645.4
13300.9
14554.7
6039.6
1197.7
969.5
607.2
501.5
314.2
430.5
512.2
672.1
536.8
599.2
435
258.9

cash-flows.row.cash-at-beginning-of-period

024533.920137.519576.4
15716.3
16605.6
13569.4
10979.7
11277.9
11190.4
12645.4
13300.9
14554.7
6210.4
4776.5
969.5
604.7
628.7
314.2
430.5
512.2
672.1
536.8
599.2
435
258.9
58.2

cash-flows.row.operating-cash-flow

05231.54743.45061.3
6844.7
6022.4
3135.1
2648.8
1946.7
1349.2
1335.7
973.4
1150.8
1772.4
1686.1
664.1
285.7
488.9
583.1
73
61.7
0.5
100.8
65.7
146.2
164.7
-283.1

cash-flows.row.capital-expenditure

0-2970.6-2684.9-4118.8
-3010
-2753.1
-1943
-2007.3
-2119.3
-1720.5
-1291.5
-905.1
-708.9
-413.5
-550.3
-80
-90.5
-192.3
-151.6
-198.1
-254.4
-169.6
-279.4
-144.7
-141.1
-52.5
-169.9

cash-flows.row.free-cash-flow

02260.92058.5942.6
3834.7
3269.3
1192.1
641.5
-172.6
-371.3
44.2
68.4
441.9
1358.9
1135.8
584.2
195.2
296.7
431.5
-125.1
-192.7
-169.1
-178.6
-79
5.1
112.2
-453

Resultatopgørelse række

Shanghai Pharmaceuticals Holding Co., Ltds omsætning oplevede en ændring på NaN% sammenlignet med den foregående periode. Bruttofortjenesten for SHPMF rapporteres til at være NaN. Virksomhedens driftsomkostninger er NaN og viser en ændring på NaN% fra sidste år. Udgifterne til afskrivninger er NaN, hvilket er en ændring på NaN% fra sidste regnskabsperiode. Driftsudgifterne rapporteres at være NaN, hvilket viser en NaN% ændring fra år til år. Salgs- og marketingomkostninger er NaN, hvilket er en ændring på NaN% sammenlignet med året før. EBITDA baseret på de seneste tal er NaN, hvilket repræsenterer en NaN% vækst i forhold til året før. Driftsindtægterne er NaN, som viser en ændring på NaN% sammenlignet med året før. Ændringen i nettoindkomsten er NaN%. Nettoindkomsten for det sidste år var NaN.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996199519941993

income-statement-row.row.total-revenue

0260295.1231981.3215824.3
191909.2
186565.8
159084.4
130847.2
120764.7
105516.6
92398.9
78222.8
68078.1
54899.9
37411.1
19568.1
16547.8
13919.8
11410.3
10699.3
10815
9785.8
7235.7
5202
4595.3
4529.9
4413.4
339.8
321
337.4
241.3
225.7

income-statement-row.row.cost-of-revenue

0228966.9201494.9187281.1
164474
159751.7
136521.5
114122.7
106530.9
92715.3
80994.1
67980.1
58792.6
46882.2
30619.9
17851.8
15101.4
12697.8
10618.3
9997.3
9794
8774.9
6215.3
4491.7
4003.8
3970
3886.7
291.8
270.4
291.9
205.8
193.8

income-statement-row.row.gross-profit

031328.130486.428543.1
27435.2
26814.1
22562.9
16724.5
14233.8
12801.3
11404.8
10242.7
9285.5
8017.7
6791.1
1716.3
1446.4
1222
792
702
1020.9
1010.9
1020.3
710.3
591.5
559.9
526.7
48
50.6
45.5
35.4
31.9

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

0-612.912.4-267.7
117.6
174.1
144.3
-23.3
484.6
522.9
547.9
185.2
271.6
187.7
183.6
-12.3
39.8
25.2
43.9
61
69.6
55.1
36.6
7.6
9.3
9.6
22
22.7
-0.3
0.4
1.4
0.7

income-statement-row.row.operating-expenses

02176321705.420616.2
19297.4
18884.5
16326.3
11747
9972.3
8846.1
8010.4
7341
6617.6
5584.3
4909.4
1112.4
1095.3
956.4
630
632
925.2
850.3
843.1
544.3
413.1
379.3
380.5
20.4
20.8
15.6
9.1
6.6

income-statement-row.row.cost-and-expenses

0250729.9223200.3207897.3
183771.4
178636.2
152847.7
125869.7
116503.2
101561.4
89004.5
75321.1
65410.2
52466.5
35529.4
18964.2
16196.7
13654.2
11248.2
10629.3
10719.2
9625.1
7058.5
5036
4416.9
4349.3
4267.2
312.2
291.2
307.5
214.9
200.4

income-statement-row.row.interest-income

0-461.8438.3338.2
288.3
234
197.4
161.4
172
138
207
242.1
304.4
262.9
47.2
10.6
8.4
20.8
18.5
19.7
23.4
15.5
7.8
8.2
17.6
0
0
0
0
0
0
0

income-statement-row.row.interest-expense

018851689.31518.2
1411.9
1405.2
1204.4
875.7
645.1
613.3
584.9
413.7
472.4
461.8
213.5
113.2
156.5
141.7
127.3
47.8
36.4
52.1
30.6
13.4
55
48.3
63.7
20.9
12
8.9
3.9
2.9

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-612.9-206.3-61.7
-8.9
48.5
135
-23.3
431.9
485.2
530.2
186.5
291.8
161.4
96
-15.8
23.1
23.9
16.9
37.5
40.7
38.4
21.9
-1
3.8
0.4
19.6
-1
-0.2
0.2
1.2
-0.2

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

0-612.912.4-267.7
117.6
174.1
144.3
-23.3
484.6
522.9
547.9
185.2
271.6
187.7
183.6
-12.3
39.8
25.2
43.9
61
69.6
55.1
36.6
7.6
9.3
9.6
22
22.7
-0.3
0.4
1.4
0.7

income-statement-row.row.total-operating-expenses

0-612.9-206.3-61.7
-8.9
48.5
135
-23.3
431.9
485.2
530.2
186.5
291.8
161.4
96
-15.8
23.1
23.9
16.9
37.5
40.7
38.4
21.9
-1
3.8
0.4
19.6
-1
-0.2
0.2
1.2
-0.2

income-statement-row.row.interest-expense

018851689.31518.2
1411.9
1405.2
1204.4
875.7
645.1
613.3
584.9
413.7
472.4
461.8
213.5
113.2
156.5
141.7
127.3
47.8
36.4
52.1
30.6
13.4
55
48.3
63.7
20.9
12
8.9
3.9
2.9

income-statement-row.row.depreciation-and-amortization

02187.12222.42139.8
2137.8
1885
1169.5
840
746.1
672.6
585
549.7
536.6
479.2
382.7
93.2
94.2
96.4
69.1
59.1
74.2
70.3
72.3
50.4
50.1
43.4
21.4
-3
11.7
8.5
3.3
1.6

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

07667.29014.78205.5
7184.4
6213.9
5208.3
5228.2
4207.1
3686.6
3269.5
3074.3
2795.9
2873.7
2076.6
370.7
163.6
122.6
84.6
61.2
150.1
219.5
191.6
203.3
218.4
137.5
89.9
30.6
18.1
21.4
23
23.7

income-statement-row.row.income-before-tax

07054.38808.48143.8
7175.5
6262.5
5343.4
5204.8
4639
4171.9
3799.7
3260.8
3087.7
3035.1
2172.5
355
186.7
146.6
101.5
98.7
190.8
257.9
213.5
202.3
222.3
137.9
109.6
29.7
17.9
21.6
24.2
23.4

income-statement-row.row.income-tax-expense

01887.71816.31869.2
1570.2
1431.7
887.1
1147
809.3
807.5
807.7
634.2
627.1
589.1
393.6
91.5
57.3
51.1
40.3
25.9
52.3
50.4
50.3
27.6
17.6
27.1
19.8
1
2.6
3.2
3.6
3.6

income-statement-row.row.net-income

037685617.25093.5
4496.2
4081
3881.1
3520.6
3196.4
2877
2591.1
2242.9
2052.9
2042.2
1368.3
173.3
82
66.3
68.7
50.5
93.1
154.4
125.8
145.3
184.8
94.4
78.7
28.7
15.2
18.3
20.6
19.9

Ofte stillede spørgsmål

Hvad er Shanghai Pharmaceuticals Holding Co., Ltd (SHPMF) samlede aktiver?

Shanghai Pharmaceuticals Holding Co., Ltd (SHPMF) samlede aktiver er 211972533766.000.

Hvad er virksomhedens årlige omsætning?

Den årlige omsætning er N/A.

Hvad er virksomhedens profitmargin?

Virksomhedens profitmargin er 0.116.

Hvad er virksomhedens frie pengestrøm?

Det frie cash flow er -0.102.

Hvad er virksomhedens nettoprofitmargin?

Nettofortjenstmargenen er 0.014.

Hvad er firmaets samlede omsætning?

Den samlede omsætning er 0.029.

Hvad er Shanghai Pharmaceuticals Holding Co., Ltd (SHPMF) nettoresultat (nettoindkomst)?

Nettoresultatet (nettoindkomsten) er 3767999581.000.

Hvad er virksomhedens samlede gæld?

Den samlede gæld er 45860206958.000.

Hvad er tallet for driftsudgifter?

Driftsudgifterne er 21762997476.000.

Hvad er firmaets likviditet?

Virksomhedens likviditet er 0.000.